000 02282nam  2200433zi 4500
0019.939425
003CaOODSP
00520240822150345
006m     o  d f      
007cr |n|||||||||
008240617e202403  onca    o    f000 0 eng d
020 |a9780660723938
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-626/2024E-PDF
24500|aOpioid overdose crisis brand and message focus testing (HCPOR #23-42) : |bfinal report / |cprepared for Health Canada.
264 1|a[Ottawa] : |bHealth Canada = Santé Canada, |cMarch 2024.
264 4|c©2024
300 |a1 online resource (1 volume (various pagings)) : |billustrations + |eexecutive summary (8 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Groupes de discussion sur l'image de marque et le message concernant la crise des surdoses d'opioïdes (HCPOR no 23-42) : rapport final.
500 |a"Prepared by Narrative Research."
500 |a"Call-Up Number: CW2346055."
500 |a"Requisition Reference Number: HT372-235452."
500 |a"POR number: 115-23."
650 0|aOpioids|xOverdose|zCanada|xPrevention|xPublic opinion.
650 0|aOpioid abuse|zCanada|xPrevention|xPublic opinion.
650 0|aGovernment advertising|zCanada|xPublic opinion.
650 0|aAdvertising campaigns|zCanada|xPublic opinion.
650 0|aPublic opinion|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tGroupes de discussion sur l'image de marque et le message concernant la crise des surdoses d'opioïdes (HCPOR no 23-42) : |w(CaOODSP)9.939426
85640|qPDF|s2766 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-626-2024-eng.pdf|zFinal report
85640|qPDF|s235 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-626-2024-1-eng.pdf|zExecutive summary
8564 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2024/115-23-e/POR115-23-report.html|zFinal report
8564 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2024/115-23-e/summary/POR115-23-summary.html|zExecutive summary